| Title |
Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, May 2020
|
| DOI | 10.1186/s40545-020-00219-1 |
| Pubmed ID | |
| Authors |
Ali Elbeddini, Aniko Yeats, Stephanie Lee |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 81 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 12 | 15% |
| Student > Bachelor | 10 | 12% |
| Other | 9 | 11% |
| Researcher | 7 | 9% |
| Student > Master | 6 | 7% |
| Other | 21 | 26% |
| Unknown | 16 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 22% |
| Nursing and Health Professions | 8 | 10% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Social Sciences | 5 | 6% |
| Economics, Econometrics and Finance | 4 | 5% |
| Other | 21 | 26% |
| Unknown | 20 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2020.
All research outputs
#18,726,447
of 23,211,181 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#362
of 418 outputs
Outputs of similar age
#294,150
of 389,742 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#21
of 22 outputs
Altmetric has tracked 23,211,181 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 418 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,742 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.